Nasdaq:US$15.02 (+1.14) | HKEX:HK$22.35 (+0.90) | AIM:£2.43 (+0.23)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 29 Jul 2009

Patient Enrolment Completed Ahead of Schedule for the Global Phase IIb Ulcerative Colitis Trial of HMPL-004

1 items
a090729